| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer. | JAMA | 2011 | 4.63 |
| 2 | Evaluation of a 30-gene paclitaxel, fluorouracil, doxorubicin, and cyclophosphamide chemotherapy response predictor in a multicenter randomized trial in breast cancer. | Clin Cancer Res | 2010 | 1.81 |
| 3 | Massive nodular melanoma: a case report. | Dermatol Online J | 2007 | 0.86 |